Abstract |
The effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in a murine model of pneumococcal pneumonia was examined. Intranasal inoculations were 10(7) cfu/mouse (high inoculum) and 5 x 10(4) cfu/mouse (low inoculum) of Streptococcus pneumoniae, which induced severe or mild lung inflammation, respectively. With the low inoculum, rhG-CSF significantly improved survival when initiated 24 h or 10 min before, but not when initiated 24 h after, infection. Pretreatment with rhG-CSF significantly increased myeloperoxidase (MPO) activity in lungs 8 h after the infection and increased circulating neutrophil count 24, 48, and 72 h after infection. In contrast, rhG-CSF did not improve survival of animals infected with the high inoculum and did not increase MPO activity or neutrophil count in blood over those of sham-treated controls. These data strongly suggest that the severe inflammatory response typically observed in pneumococcal pneumonia recruits a maximum number of neutrophils in the lungs and thus masks the beneficial effect of rhG-CSF.
|
Authors | F Dallaire, N Ouellet, M Simard, Y Bergeron, M G Bergeron |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 183
Issue 1
Pg. 70-7
(Jan 01 2001)
ISSN: 0022-1899 [Print] United States |
PMID | 11087202
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Granulocyte Colony-Stimulating Factor
- Peroxidase
|
Topics |
- Animals
- Disease Models, Animal
- Female
- Granulocyte Colony-Stimulating Factor
(therapeutic use)
- Humans
- Leukocyte Count
- Lung
(drug effects, immunology, metabolism)
- Mice
- Neutrophils
(immunology)
- Peroxidase
(metabolism)
- Pneumonia, Pneumococcal
(blood, drug therapy, metabolism)
- Streptococcus pneumoniae
- Time Factors
|